This week, hosts Mark Masselli and Margaret Flinter look back at some of the most memorable guests from 2018, which included thought leaders in areas such as CRISPR gene editing technology, Artificial Intelligence and Voice in health care, the rise of innovative care delivery models as well as the transformation in health profession training. They also welcomed award-winning investigative journalists who exposed the dark side of the health industry in which corporations profited from defrauding the public and putting patients’…
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. John Moore, Medical Director of Fitbit, on their newly launched Fitbit Care – a digitally supported personal health and fitness coaching platform that provides personalized support 24/7. Dr. Moore talks about the platform’s ability to help participants set achievable goals, linking their real time data to health coaches through their digital technology.
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Norman Sharpless, Director of the National Cancer Institute at the National Institutes of Health. They discuss the accelerated pace of discovery in cancer research driven by genomics, big data analytics and personalized oncology. He also stresses the need to address fragmented pockets of research for more rapid deployment of treatment breakthroughs.
This week, hosts Mark Masselli and Margaret Flinter speak with Noelle LaCharite Principal Program Manager for Applied AI and Cognitive Services at Microsoft, and one of the original voice ‘skills’ developers for Amazon’s Alexa. She talks about the promise of applied AI, machine learning and voice technology systems which enable coders, developers or anyone to create their own applications and voice skills to enhance and advance the health care experience.
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Sue Sisley, internist, psychiatrist and President of the Scottsdale Research Institute which is conducting the nation’s only FDA-approved study on the efficacy of whole plant marijuana for treatment of PTSD. She discusses her ten-year quest to complete a randomized control trial on the use of cannabis as a potentially effective approach, and restrictions that pose a challenge to expansive scientific research.
This week hosts Mark Masselli and Margaret Flinter speak with Dr. Charles Alessi, Senior Advisor for Dementia Prevention at Public Health England, the UK’s equivalent of the CDC. Dr. Alessi talks about the prevention strategies being deployed across the UK to delay the onset of dementia, the lack of barriers to primary care services, and their recently announced Minister of Loneliness to confront this chronic health issue.